Phospho-STAM2 (Y192) Antibody

What is STAM2 and what is the biological significance of its Y192 phosphorylation?

STAM2 (Signal Transducing Adapter Molecule 2) is a ubiquitously expressed protein involved in intracellular signal transduction mediated by cytokines and growth factors. Upon IL-2 and GM-CSF stimulation, it plays a crucial role in signaling pathways leading to DNA synthesis and MYC induction . STAM2 is also known as HBP (Hrs-binding protein) and functions as a component of the ESCRT-0 complex with HGS, which is involved in the down-regulation of receptor tyrosine kinases via multivesicular bodies (MVBs) .

The phosphorylation of STAM2 at tyrosine 192 (Y192) is a critical post-translational modification that occurs in response to cytokine stimulation. This phosphorylation is mediated by JAK kinases and appears to be essential for STAM2's role in signaling cascades . Y192 phosphorylation likely regulates protein-protein interactions within signaling complexes, potentially affecting the recruitment of downstream effectors in pathways related to cell proliferation and receptor trafficking.

What detection methods can be effectively employed with Phospho-STAM2 (Y192) antibody?

Phospho-STAM2 (Y192) antibodies have been validated for multiple experimental applications:

• Western Blotting (WB): The primary application, typically using dilutions between 1:500-1:1000 . This method allows detection of the ~58 kDa phosphorylated STAM2 protein in cell and tissue lysates.

• Immunohistochemistry-Paraffin (IHC-P): Enables visualization of phospho-STAM2 localization in fixed tissue sections, with human lung tissue sections being a reported positive control .

• Enzyme-Linked Immunosorbent Assay (ELISA): Can be used for quantitative detection of phospho-STAM2 levels in purified or semi-purified protein preparations .

For optimal results, researchers should validate antibody performance in their specific experimental systems and optimize conditions for each application.

What are the proper storage and handling protocols for preserving Phospho-STAM2 (Y192) antibody activity?

To maintain antibody performance and stability:

• Store the antibody at -20°C for long-term storage .

• Aliquot the antibody upon first thawing to minimize freeze-thaw cycles, which can degrade antibody performance .

• The antibody is typically provided in a buffer containing 50% glycerol, PBS, and 0.02-0.05% sodium azide at pH 7.2-7.4 .

• When working with the antibody, keep it on ice or at 4°C.

• Some formulations may include stabilizers like 0.5% BSA .

• The antibody is generally stable for at least 12 months when properly stored at -20°C .

For short-term storage (less than one week), the antibody can be kept at 4°C, but this should be minimized to prevent potential degradation over time.

What control samples should be included when using Phospho-STAM2 (Y192) antibody?

For rigorous experimental design, include the following controls:

• Positive Control: NIH/3T3 cytoplasmic lysate has been validated as a positive control . HEK293T cells or sp2/0 cells treated with EGF (0.1 ng/mL for 30 minutes) have also demonstrated positive signals .

• Negative Control:

  • Lysates from unstimulated cells (without cytokine/growth factor treatment) to demonstrate specificity for the phosphorylated form.

  • Lysates treated with phosphatase to remove phosphorylation sites.

  • Non-specific rabbit IgG at equivalent concentration to assess background binding.

• Blocking Peptide Control: Competition assays using the immunizing phosphopeptide can confirm antibody specificity.

• Loading Control: Include detection of total STAM2 (with a non-phospho-specific antibody) or other housekeeping proteins to normalize for protein loading and transfer efficiency.

How can researchers experimentally induce STAM2 Y192 phosphorylation for positive control samples?

STAM2 Y192 phosphorylation can be induced through several experimental approaches:

• Growth Factor Stimulation: Treatment with EGF (0.1 ng/mL for 30 minutes) has been demonstrated to induce Y192 phosphorylation in HEK293T and sp2/0 cells .

• Cytokine Stimulation: Treatment with IL-2 or GM-CSF, which activate JAK kinases that subsequently phosphorylate STAM2 .

• JAK Activation: Direct activation of JAK2 or JAK3, which are the kinases responsible for STAM2 phosphorylation following cytokine stimulation .

• Phosphatase Inhibition: Treatment with sodium orthovanadate or other tyrosine phosphatase inhibitors can increase detectable levels of phosphorylated STAM2 by preventing dephosphorylation.

To verify successful induction, run parallel Western blots probing for both phospho-STAM2 (Y192) and total STAM2 to calculate the relative phosphorylation levels.

What methodological approaches can address weak or inconsistent signals when using Phospho-STAM2 (Y192) antibody?

When encountering detection challenges:

• Sample Preparation Optimization:

  • Include phosphatase inhibitors (sodium orthovanadate, sodium fluoride) in lysis buffers.

  • Maintain samples at 4°C during preparation to minimize dephosphorylation.

  • Consider using specialized phosphoprotein extraction buffers.

• Western Blot Protocol Refinement:

  • Increase antibody concentration (try 1:250 instead of 1:500).

  • Extend primary antibody incubation time (overnight at 4°C).

  • Use high-sensitivity detection systems (enhanced chemiluminescence substrates).

  • Try PVDF membrane instead of nitrocellulose for potentially better protein retention.

  • Optimize blocking conditions (BSA may be preferable to milk for phospho-epitopes).

• Signal Enhancement Strategies:

  • Enrich phosphoproteins prior to analysis using phosphoprotein enrichment kits.

  • Concentrate the protein sample using immunoprecipitation with total STAM2 antibody before probing with phospho-specific antibody.

  • Consider tyrosine phosphatase inhibitor pretreatment of cells to increase phosphorylation levels.

• Antibody Validation:

  • Verify antibody activity using a dot blot with the immunizing phosphopeptide.

  • Test a new antibody lot if problems persist.

How does STAM2 phosphorylation at Y192 relate to ESCRT-0 complex function and receptor trafficking?

STAM2 functions as a component of the ESCRT-0 (Endosomal Sorting Complex Required for Transport-0) complex, which plays a critical role in the sorting and trafficking of ubiquitinated membrane receptors . The relationship between Y192 phosphorylation and these functions involves several aspects:

• Regulatory Mechanism: Phosphorylation at Y192 likely represents a regulatory switch affecting STAM2's ability to interact with other components of the endosomal sorting machinery.

• Complex Assembly: Y192 phosphorylation may modulate STAM2's interaction with HGS (Hepatocyte Growth Factor-Regulated Tyrosine Kinase Substrate), the other main component of ESCRT-0. This interaction is crucial for recognizing ubiquitinated cargo destined for lysosomal degradation.

• Trafficking Dynamics: The phosphorylation state of STAM2 potentially influences the rate of receptor internalization and sorting toward degradative pathways versus recycling pathways.

• Signaling Integration: Y192 phosphorylation could serve as an integration point between cytokine/growth factor signaling and receptor downregulation pathways, providing a mechanism for feedback regulation.

To experimentally investigate these relationships, researchers could employ phosphomimetic mutants (Y192E) or phospho-deficient mutants (Y192F) of STAM2 and assess their impact on:

• ESCRT-0 complex formation (co-immunoprecipitation assays)

• Receptor internalization rates (surface biotinylation assays)

• Receptor degradation kinetics (pulse-chase experiments)

• Subcellular localization patterns (immunofluorescence microscopy)

What are the optimal conditions for detecting phospho-STAM2 (Y192) in different cell types and tissues?

Optimization strategies vary by experimental system:

For Cell Lines:

• HEK293T and NIH/3T3 cells have been validated as suitable models .

• Stimulation timing: For EGF stimulation, 30 minutes has been reported as effective .

• Lysis conditions: Use RIPA buffer supplemented with protease inhibitors and phosphatase inhibitors (10 mM sodium fluoride, 1 mM sodium orthovanadate, 1 mM β-glycerophosphate).

• Protein loading: 30-50 μg of total protein per lane is typically sufficient.

For Tissue Samples:

• Human lung tissue has been validated for IHC-P applications .

• Rat spleen tissue has shown detectable phospho-STAM2 signal in Western blot .

• Fixation for IHC: 10% neutral buffered formalin fixation followed by paraffin embedding.

• Antigen retrieval: Heat-mediated antigen retrieval in citrate buffer (pH 6.0) is recommended.

• Tissue extraction: For Western blot analysis, homogenize tissues in RIPA buffer with phosphatase inhibitors at 4°C.

For Both Sample Types:

• Sample handling: Process samples immediately after collection and maintain at 4°C.

• Antibody dilution: Start with manufacturer's recommendation (typically 1:500-1:1000) and optimize if needed.

• Incubation conditions: Overnight at 4°C generally yields optimal results for primary antibody.

How can researchers validate phospho-specific antibodies for STAM2 to ensure specificity?

A comprehensive validation approach includes:

• Phosphatase Treatment Control:

  • Split your positive control sample into two aliquots

  • Treat one aliquot with lambda phosphatase to remove phosphorylation

  • Both treated and untreated samples should be run on the same blot

  • A valid phospho-specific antibody will show diminished signal in the phosphatase-treated sample

• Peptide Competition Assay:

  • Pre-incubate the antibody with excess immunizing phosphopeptide

  • A specific antibody will show blocked detection when pre-incubated with its target phosphopeptide

  • Include a non-phosphorylated peptide control to confirm phospho-specificity

• Genetic Validation:

  • Use CRISPR/Cas9 to generate Y192F mutant cell lines

  • Compare antibody reactivity between wild-type and mutant cells

  • Specific antibodies will show no reactivity with the Y192F mutant

• Induction and Inhibition Validation:

  • Stimulate cells with appropriate cytokines/growth factors

  • Treat parallel samples with JAK inhibitors to prevent phosphorylation

  • Compare signal intensity between conditions

• Cross-Reactivity Assessment:

  • Test antibody against recombinant phosphorylated and non-phosphorylated STAM2

  • Also test against closely related family members (e.g., STAM1) to assess specificity

What experimental designs are recommended for studying STAM2 phosphorylation dynamics in cytokine signaling?

Comprehensive experimental designs should include:

• Time-Course Analysis:

  • Stimulate cells with IL-2 or GM-CSF

  • Collect samples at multiple timepoints (0, 5, 15, 30, 60, 120 minutes)

  • Analyze phospho-STAM2 levels by Western blotting

  • Plot the phosphorylation kinetics to determine peak activation

• Dose-Response Relationship:

  • Treat cells with varying concentrations of cytokines

  • Determine the minimum concentration required for detectable phosphorylation

  • Establish an EC50 value for STAM2 phosphorylation

• Pathway Delineation:

  • Use specific inhibitors to block different components of the signaling pathway:

    • JAK inhibitors (e.g., ruxolitinib for JAK1/2)

    • Src family kinase inhibitors

    • PI3K inhibitors

  • This approach helps map the requirement of each kinase for STAM2 phosphorylation

• Co-immunoprecipitation Studies:

  • Immunoprecipitate phospho-STAM2 at different timepoints after stimulation

  • Analyze co-precipitating proteins by mass spectrometry

  • Identify dynamic interaction partners that associate specifically with the phosphorylated form

• Functional Correlation:

  • Correlate STAM2 phosphorylation timing with downstream events:

    • MYC induction

    • DNA synthesis (BrdU incorporation)

    • Receptor internalization rates

This multi-faceted approach provides a comprehensive understanding of STAM2 phosphorylation dynamics and functional consequences.

How do different fixation methods affect Phospho-STAM2 (Y192) epitope detection in immunohistochemistry?

Fixation methodology significantly impacts phospho-epitope preservation:

• Formalin Fixation (10% Neutral Buffered Formalin):

  • Standard method that generally preserves phospho-epitopes

  • Recommended fixation time: 24-48 hours for tissue blocks

  • Requires heat-mediated antigen retrieval (citrate buffer pH 6.0 or EDTA buffer pH 9.0)

  • Human lung FFPE tissue sections have been validated as suitable for phospho-STAM2 detection

• Paraformaldehyde Fixation (4% PFA):

  • Milder than formalin, may better preserve some phospho-epitopes

  • Recommended for cell preparations and thin tissue sections

  • Shorter fixation times (10-20 minutes for cells, 24 hours for tissues)

  • May require less aggressive antigen retrieval

• Methanol/Acetone Fixation:

  • Often unsuitable for phospho-epitopes due to potential dephosphorylation

  • Avoid for phospho-STAM2 detection unless specifically validated

• Zinc-Based Fixatives:

  • May better preserve certain phospho-epitopes than aldehyde-based fixatives

  • Less common but worth testing if standard methods fail

• PAXgene Tissue Fixation:

  • Newer method that preserves phosphoproteins better than formalin

  • Consider for prospective studies specifically focused on phosphoprotein analysis

Optimization recommendations:

• Always include a known positive control sample

• Test multiple antigen retrieval methods (heat-induced vs. enzymatic)

• Consider dual pH antigen retrieval protocols

• Phosphatase inhibitor addition to fixatives may help preserve phospho-epitopes

What are the practical considerations for using Phospho-STAM2 (Y192) antibody in phosphoproteomic studies?

When incorporating phospho-STAM2 (Y192) antibody into phosphoproteomic workflows:

• Antibody-Based Enrichment:

  • Use phospho-STAM2 antibody for immunoprecipitation to enrich phosphorylated STAM2

  • Combine with mass spectrometry to identify associated proteins and additional phosphorylation sites

  • Critical consideration: Ensure antibody has minimal cross-reactivity with other phosphoproteins

• Multiplexed Detection:

  • When multiplexing with other phospho-specific antibodies, verify absence of spectral overlap

  • For fluorescence-based detection, choose fluorophores with minimal crosstalk

  • Consider sequential detection rather than simultaneous if signal interference occurs

• Quantitative Analysis:

  • For quantitative Western blotting, establish a standard curve using recombinant phosphorylated STAM2

  • Consider digital protein expression systems for more precise quantification

  • Use phosphorylation-specific normalization controls

• Sample Preparation:

  • Rapid inactivation of phosphatases is crucial (flash freezing, phosphatase inhibitors)

  • Consider phosphopeptide enrichment techniques (TiO2, IMAC) when working with complex samples

  • Optimize digestion conditions if planning tryptic digestion for MS analysis

• Data Integration:

  • Correlate antibody-based detection with MS-based phosphoproteomic data

  • Use bioinformatic tools to place STAM2 phosphorylation in the context of the broader phosphoproteome

  • Consider pathway enrichment analysis to identify functional consequences

• Technical Validation:

  • Include synthesized phosphopeptides as technical standards

  • Use AQUA peptides for absolute quantification if needed

  • Validate key findings with orthogonal methods (e.g., Phos-tag gels)

What is the proposed mechanism by which Y192 phosphorylation alters STAM2 function in the ESCRT machinery?

While the exact molecular mechanism remains under investigation, current understanding suggests:

• Conformational Changes:

  • Y192 phosphorylation likely induces structural changes in STAM2

  • These conformational alterations may expose or mask interaction domains

  • Molecular modeling suggests Y192 is positioned near domains involved in protein-protein interactions

• Complex Formation Dynamics:

  • Phosphorylation may modulate the affinity of STAM2 for HGS, affecting ESCRT-0 assembly

  • The ESCRT-0 complex functions as a sorting machinery that recognizes ubiquitinated receptors

  • Altered phosphorylation state could change the efficiency of ubiquitinated cargo recognition

• Regulatory Switch:

  • Y192 phosphorylation potentially acts as a molecular switch between STAM2's roles in:

    • Signal transduction (cytokine/growth factor pathways)

    • Receptor trafficking (endosomal sorting)

  • This dual functionality allows for integrated cellular responses

• Functional Consequences:

  • Enhanced phosphorylation may accelerate receptor degradation pathways

  • Alternatively, it could promote signaling pathway activation before receptor downregulation

  • The temporal dynamics of phosphorylation likely determine the balance between these functions

• Interaction with Ubiquitin System:

  • STAM2 contains ubiquitin-binding domains

  • Y192 phosphorylation may alter the affinity or specificity for different ubiquitin chain topologies

  • This would affect which ubiquitinated cargoes are preferentially sorted by the ESCRT-0 complex

How does STAM2 Y192 phosphorylation coordinate with other post-translational modifications in signal integration?

STAM2 likely serves as an integration hub for multiple signaling inputs:

• Phosphorylation Crosstalk:

  • STAM2 contains multiple phosphorylation sites beyond Y192

  • These sites may be targeted by different kinases (e.g., JAK family, Src family, serine/threonine kinases)

  • Hierarchical phosphorylation patterns could create a phospho-code that determines functional outcomes

• Ubiquitination Interplay:

  • STAM2 itself can be ubiquitinated

  • Y192 phosphorylation may influence STAM2's own ubiquitination state

  • The interplay between phosphorylation and ubiquitination creates a complex regulatory network

• Pathway Integration:

  • JAK-mediated phosphorylation connects STAM2 to cytokine signaling pathways

  • Growth factor receptor-activated kinases provide input from RTK pathways

  • This positions STAM2 as an integration point for diverse extracellular signals

• Temporal Coordination:

  • Different post-translational modifications likely occur with distinct kinetics

  • The specific sequence and timing of modifications may determine the functional outcome

  • This creates a dynamic signaling system responsive to changing cellular conditions

• Spatial Regulation:

  • Different modifications may predominate in different subcellular compartments

  • Y192 phosphorylation might be more prevalent in endosomal compartments involved in receptor sorting

  • This contributes to compartmentalized signaling responses

Understanding this complex network requires multimodal analytical approaches combining phospho-specific detection with other post-translational modification analyses.

What are potential research directions for studying the role of STAM2 Y192 phosphorylation in disease contexts?

Several promising research avenues warrant investigation:

• Cancer Biology:

  • Examine Y192 phosphorylation status across cancer types and stages

  • Investigate correlation with receptor tyrosine kinase overexpression

  • Assess impact on cancer cell proliferation, migration, and therapy resistance

  • Potential focus areas: growth factor-dependent cancers, JAK/STAT-driven malignancies

• Immune Disorders:

  • Given STAM2's role in cytokine signaling and T-cell development , investigate:

    • Y192 phosphorylation in autoimmune conditions

    • Impact on immune cell activation thresholds

    • Role in cytokine receptor downregulation during inflammation resolution

• Neurodegenerative Diseases:

  • Study STAM2 phosphorylation in the context of:

    • Protein aggregation disorders (where ESCRT machinery dysfunction is implicated)

    • Neuronal endosomal trafficking abnormalities

    • Neurotrophin receptor processing and signaling

• Lysosomal Storage Disorders:

  • Investigate whether abnormal STAM2 phosphorylation contributes to:

    • Disrupted endolysosomal trafficking

    • Impaired receptor degradation

    • Altered cell signaling in affected tissues

• Therapeutic Targeting:

  • Develop tools to modulate STAM2 phosphorylation:

    • Small molecule modulators of Y192 phosphorylation

    • Phosphomimetic peptides for research applications

    • Targeted degradation approaches (PROTACs) for phospho-STAM2

• Biomarker Development:

  • Assess phospho-STAM2 as a potential biomarker for:

    • JAK/STAT pathway activation in inflammatory diseases

    • Receptor trafficking dysregulation

    • Response to kinase inhibitor therapies